XACDURO

LIVE

Serial Number

88156761

Owner

Entasis Therapeutics Limited

Attorney

Keith Toms, Esq.

Filing Date

Oct 16, 2018

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

XACDURO Trademark

Serial Number: 88156761 • Registration: 5811083

XACDURO is a trademark filed by Entasis Therapeutics Limited on October 16, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Entasis Therapeutics Limited (3 trademarks)

3rd Floor, 1 Ashley Road
Altrincham Cheshire WA14 2DT

Entity Type: 99

ENTASIS THERAPEUTICS INC. (5 trademarks)

1209 ORANGE STREET
WILMINGTON, DE 19801

Entity Type: 03

Legal Representation

Attorney of Record

Keith Toms, Esq.

1,308 trademarks filed View all →

Correspondence Address

Keith Toms, Esq. MCCARTER & ENGLISH, LLP

265 FRANKLIN STREET

BOSTON, MA 02110

United States

Trademark Details

Filing Date

October 16, 2018

Registration Date

July 23, 2019

Published for Opposition

May 7, 2019

Goods & Services

Pharmaceutical preparations, namely, antibiotics

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

May 6, 2026 NAS8

REGISTERED - SEC. 8 (6-YR) ACCEPTED

May 6, 2026 8.OK

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

Apr 22, 2026 EROP

POST REGISTRATION ACTION MAILED - SEC. 8

Mar 1, 2026 PRA8

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Feb 23, 2026 APRE

TEAS SECTION 8 RECEIVED

Oct 6, 2025 ES8R

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

May 14, 2025 ASGN

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Jul 23, 2024 REM1

REGISTERED-PRINCIPAL REGISTER

Jul 23, 2019 R.PR

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

May 7, 2019 NPUB

PUBLISHED FOR OPPOSITION

May 7, 2019 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Apr 17, 2019 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 25, 2019 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Mar 4, 2019 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Mar 4, 2019 CRFA

ASSIGNED TO LIE

Feb 26, 2019 ALIE

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

Feb 21, 2019 ERSI

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

Jan 26, 2019 GNS3

LETTER OF SUSPENSION E-MAILED

Jan 26, 2019 GNSL

SUSPENSION LETTER WRITTEN

Jan 26, 2019 CNSL

ASSIGNED TO EXAMINER

Jan 25, 2019 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Oct 26, 2018 NWOS

NEW APPLICATION ENTERED

Oct 19, 2018 NWAP

Related Trademarks

More from this Owner

XULDURO

ENTASIS THERAPEUTICS

More in Same Class

POWER YOUR BIOLOGY. PRODUCE MORE WITH BIOWISH.